Rankings
▼
Calendar
PMVP Q1 2025 Earnings — PMV Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
PMVP
PMV Pharmaceuticals, Inc.
$88M
Q1 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$22M
Net Income
-$17M
EPS (Diluted)
$-0.34
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$18M
Free Cash Flow
-$18M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$171M
Total Liabilities
$11M
Stockholders' Equity
$160M
Cash & Equivalents
$51M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
-$362,000
+100.0%
Operating Income
-$22M
-$18M
-18.3%
Net Income
-$17M
-$15M
-14.2%
← FY 2025
All Quarters
Q2 2025 →